H&T Presspart will expand cleanroom facilities and add a new production line to manufacture Kindeva Drug Delivery‘s dose counters and dose indicators for use in Chiesi MDIs, the companies have announced. According to the announcement, the dose counters will be used in Chiesi’s new lower-GWP MDIs. H&T Presspart previously signed a licensing deal with 3M (now Kindeva) in 2014 to allow the company to sell 3M dose counters and indicators.
Kindeva Global Chief Commercial Officer David Stevens commented, “Kindeva is pleased to extend this strategic partnership as it solidifies our core objective of improving the lives of patients around the world. Kindeva embraces the responsibility it has in ensuring that patients who depend upon our device technology are reliably supplied, and we believe that this innovative supply chain collaboration further underscores this commitment.”
H&T Presspart President Christian Kraetzig said, “With our expertise in device industrialization and manufacturing, this agreement marks another step in our journey to becoming a leading development and contract manufacturing partner in drug delivery devices.”
Chiesi Group Head of Global Direct Procurement Roberto Della Valle added, “Chiesi, with its patient-centric approach, is dedicated to delivering therapeutic solutions that enhance patients’ health and quality of life. Collaborating with Kindeva and H&T Presspart exemplifies this commitment, and we are thrilled to take this step forward. By providing an inhaler that reassures patients about the remaining dose count, we aim to enhance their safety and confidence.”
Read the Kindeva Drug Delivery, H&T Presspart, and Chiesi press release.
